To demonstrate the impact of this microfluidic chip for molecular diagnostics, gold-nanoprobe (Au-nanoprobe) assays were applied in the detection of BCR-ABL1 fusion transcript (RNA), which is the molecular hallmark of chronic myeloid leukemia (CML). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.